News from the Front in War on Cancer--Mission Not Accomplished

Scientific American

Janet Rowley noticed something odd about the glowing chromosomes revealed by her microscope. It was the early 1970s, the first years of the so-called "war on cancer," and she was using a new staining technique to examine cells from patients with chronic myelogenous leukemia (CML), a cancer of the blood that was almost always fatal. The technique highlighted bands within the chromosomes, and she could see an extra piece on the end of chromosome 9. That fragment was nearly the same size as a "missing" chunk of chromosome 22 that other researchers had detected a decade earlier. To Rowley, it looked as if the tips of these two chromosomes had swapped places, or translocated. During the next few years she found two other cases of chromosomal translocation in different forms of leukemia. The finds forever changed the way scientists thought about cancer.

Shuffled chromosomes in leukemia established that broken, scrambled and messed-up genes cause cancer. The genetic code details when cells should grow, divide and eventually die. Cancer is a disease of misinformation—cells ignore the rules, growing despite multiple molecular signals telling them to stop and invading other tissues because they no longer respond to biological messages to stay put or even destroy themselves. In the past four decades scientists have identified thousands of genetic mistakes that either cause cancer or boost the risk of developing it. The effects of these typos are sometimes dramatic—the gene variants BRCA1 and BRCA2 can boost women's lifetime risk of developing breast cancer from 12 percent to 60 percent. Some errors are found only in cancer cells themselves; other changes can be passed from generation to generation. The latter are the mistakes that may be passed down and boost the risk of developing cancer—this is the inherited genetic risk, or the reason that people with a familial history of a disease may want to get tested earlier or more often.

As researchers uncover more genetic mistakes and delve deeper into the human genome, it may be possible to pin down the exact probabilities conferred by inherited genetic risk. If clinicians could scan a healthy person's genes for variations that explain their probability of developing cancer, perhaps they could prevent or catch the disease before it became a problem: Spit into this vial and the doctor will tell you what will ail you in 20 years.

Despite the plummeting cost of DNA sequencing technology, much of the information is a jumble of alphabet soup. Science can figure out what gene variants and markers a person has, but they can't tell exactly what it means for his or her health. It will take researchers years to untangle the genetics of cancer. Even large steps, heralded as a major advances, answer few questions and pose many more.

This spring, a massive international collaboration doubled the number of known genetic regions associated with the risk of breast, prostate or ovarian cancers. The genetic markers are signpost that researchers can follow to better understand the biology of these cancers. Only a few of the 74 newly identified markers are shared by more than one type of cancer, underscoring cancer's complexity. Yet exactly how the findings can inform public health recommendations remains to be discovered. Each marker is associated with small modifications of risk, but the effects add up. The findings could lead to more accurate cancer screening and hint at ways cancers could be caught before the disease becomes aggressive. Only further study, however, will show where to draw the lines between risk percentages that tell patients "not to worry" or "get tested now."

Reams of data

The impressive number of hits in the new work stems from the size of the research effort: 160 institutions around the world analyzed a pool of more than 200,000 individuals' genetic sequences. The international project is called the Collaborative Oncological Gene-environment Study (COGS). To find the dozens of new cancer risk regions, researchers combed the pooled genetic information for variations called single-nucleotide polymorphisms (SNPs). A SNP is change in a single letter of the DNA code, likely introduced as a "typo" during gene replication. If such a change happens within a gene, it can affect the structure of proteins. If it falls within a stretch of DNA that regulates genes, it can affect the amount of protein a cell produces.

The COGS researchers put 211,000 SNPs of interest, which were previously identified in other studies, on a custom-made DNA array that looks a bit like a computer chip. Then they used the chip to scan the pooled genetic information to look for differences between people who had cancer and those who did not. If a particular SNP popped up more often in the group of people who had cancer, that SNP could be linked to increased risk for that cancer.

Most of the SNPs the cancer teams identified are specific to one of the three cancers, but 17 are shared risk factors for all three. The new SNPs, combined with 75 previously known markers, explain a proportion of inherited genetic risk for these cancers: 28 percent for breast, 4 percent for ovarian and 30 percent for prostate cancer. The research was published as a collection of 13 papers in April in Nature Genetics, Nature Communications, PLoS Genetics, The American Journal of Human Genetics, and Human Molecular Genetics (Scientific American is part of Nature Publishing Group).

Comparing genomes to uncover SNPs of interest is one way that researchers dig down to find the genetic basis of complex diseases. "We get little bits that we put together," says Stephen Chanock, chief of the Laboratory of Translation Genomics at the National Cancer Institute. Chanock was involved in several of the new studies. Complex diseases such as cancer spring from many gene variants that all contribute to the disease. These studies are helping researchers fill in the list of risky genetic markers. "What is emerging is the complicated genetic architecture of different diseases," he says.

Following the signs

Rowley's swapped chromosomes eventually led researchers to find a way to treat CML. Now patients can take a pill that jams a monkey wrench into a process vital to the cancer's development. The drug, called imatinib (first marketed as Gleevec in the U.S.), often grants patients a normal life expectancy with minimal side effects. Few cancer treatments have met this high bar, but researchers still comb the genome for cancer's fingerprints and clues to what might stop the disease.

Indeed, the COGS findings provide signposts for future research. For example, a handful of SNPs associated with prostate cancer risk fall within genes important for the binding of a cell to a surface. That surface could be another cell to facilitate communication or create a barrier through which pathogens cannot pass. Cell–cell adhesion is important for immune response and is also involved in tumor metastasis—tumor cells use cell adhesion to stick to a new location in the body. Understanding the mechanisms for cell–cell adhesion may offer insights for new treatments.

In a number of regions the SNPs are involved in more than one type of cancer cluster. "In some cases we are beginning to understand why that is," said Doug Easton, a professor at the University of Cambridge and the lead author of the main breast cancer paper at a press conference before the papers were published. One of the COGS papers honed in on a genetic region that helps control the length of telomeres, which are protective caps on the end of DNA strands. The so-called TERT locus harbors SNPs relevant to both breast and ovarian cancer risk, making it a prime candidate for further study.

The next step for the international cancer teams is an even larger study with a new chip called OncoChip, made by Signature Genomics. They plan to screen 600,000 SNPs of interest to see if they are involved five malignancies—ovarian, breast and prostate as well as colorectal and lung cancers. The larger numbers will give the researchers more statistical power to uncover less common gene variants. In addition researchers will map the already discovered variants to figure out which genes and biochemical pathways are involved. Studies of gene function are critical to characterize cancer biology, says Mathieu Lupien, a scientist at the Ontario Cancer Institute and assistant professor at the University of Toronto who was not involved in COGS. "Now we can move forward and understand why it is those genetic defects promote cancer," he says.

Weighing the risks

Genetic markers may lead to better treatments, but researchers also hope to catch cancer before it starts.

Clinicians already use cancer-risk calculators to group people into high- and low-risk categories based on lifestyle choices, environment and family history. The new SNPs could be additional indicators that make the stratification more accurate and efficient. High-risk groups could get targeted recommendations for avoiding risky behaviors or whether to get screened for a type of cancer.

Currently, cancer screening is saddled with a lot of false positives, which means people who do not have cancer are told they are positive. Such results lead to unnecessary and even dangerous procedures—not to mention the anxiety felt by those who believe they have a potentially life-threatening disease. For example, screening for prostate, lung, colorectal and ovarian cancers in 68,436 people over a period of three years led to a least one false positive for 60 percent of men and 49 percent of women. Another study found that follow-up procedures (such as a biopsy) after a false positive cost an average of $1,024 for women and $1,171 for men. The challenge is figuring out where to draw the line for high-risk, says Ros Eeles, a professor of oncogenetics at the Institute of Cancer Research in London and one of the principal investigators involved in the main prostate cancer paper. "We could do the test and give a risk profile, but we don't know what you should do when you have the information," she says. Studies that retroactively profile genetic risk markers in patients could reveal where the lines should fall and what interventions are most effective.

"We're not to the point of being able to predict an individual's risk," says Joe Gray, a professor at Oregon Health & Science University's Knight Cancer Institute and not involved in the COGS studies. A more thorough understanding of risk factors and better cancer screening could lead to a future where doctors can "prevent people from having cancer we don't know how to treat," he says.

More information about how different genetic variants contribute to risk of disease could help refine the definition of high-risk groups. A well-tested SNP profile could sort out individuals at the top of the spectrum, where the benefits of screening would outweigh the risks. Once the genetic risk is understood, public health professionals can employ the same communication strategies used to counsel people about heart disease risk. "We do [stratified screening] all the time with cardiovascular risk," says Hilary Burton, director of the PHG Foundation based in England. Right now the evidence on breast cancer screening is "finely balanced between benefits and harm," she says. The newly identified SNPs can help tip the balance for some carefully identified individuals.

The vision the researchers outline could be in the not-too-distant future. People in their 40s today might see safer, stratified risk screening for some cancers within their lifetimes, Cambridge’s Easton said in a press conference. Still, before all patients can receive the benefits of safe screening, researchers will need to address a gap common to current genome-based discoveries: The 200,000 people in the COGS pool are largely of European descent and live Australia, North America and Europe. Whereas the consortium did find some risk markers specific to people of Asian descent, other genetic groups such as African and indigenous populations in the Americas and Australia are underrepresented.

"We are still very much in the discovery mode," Chanock says. Decades after uncovering the genetic basis of cancer, that is a sobering statement.

Follow Scientific American on Twitter @SciAm and @SciamBlogs.

Visit ScientificAmerican.com for the latest in science, health and technology news.

© 2013 ScientificAmerican.com. All rights reserved.

Sorry you didn't like this comment. Please provide a reason below.

Are you sure?
Rating failed. Try again.
Request failed. Try again.
We will promote constructive and witty comments to the top, so everyone sees them!
Sorry, we can’t load comments right now. Try again.

    Recommended for You

    • Trump poised to take executive actions on first day in office

      Donald Trump is preparing to begin taking executive actions on his first day in the White House on Friday to roll back policies of outgoing President Barack Obama and implement parts of his plans to crack down on immigration and build a wall on the U.S.-Mexican border. Trump, a Republican who was elected on Nov. 8 and will be sworn in during a ceremony at the U.S. Capitol on Friday, is poised to wield one of the most powerful tools of his office, the presidential pen, for executive actions that can be implemented without the input of Congress. "He is committed to not just Day 1, but Day 2, Day 3 of enacting an agenda of real change, and I think that you're going to see that in the days and weeks to come," Trump spokesman Sean Spicer said on Thursday, telling reporters to expect activity on Friday, during the weekend and early next week.

      Reuters
    • Cancer Patient Who Did 'Juju on That Beat' During Chemo in Viral Video Dies

      Ana-Alecia Ayala, who made headlines in October for dancing up a storm during chemotherapy treatments, has died after a year-long battle against cancer.

      Inside Edition
    • Documents: Woman knew for months she'd been stolen at birth

      An 18-year-old who was kidnapped as an infant discovered months ago that she had been raised by her abductor under an assumed name, court documents show.

      Associated Press 37 min ago
    • Deadly snow avalanche hits hotel in earthquake-stricken central Italy (15 photos)

      Rescue workers were met with an eerie silence Thursday when they reached a four-star spa hotel struck by an avalanche in a mountainous earthquake-stricken region of central Italy. At least 30 people were missing, including at least two children, authorities said. Guests at the three-story Hotel Rigopiano in the central Abruzzo region alerted emergency workers of the disaster on Wednesday, following a series of quakes in the region. “Help, we’re dying of cold,” one couple wrote rescuers, according to the ANSA news agency. Another man, identified by news reports as Fabio Salzetta, sent a SMS message saying he had escaped with a maintenance worker, but that others were trapped inside. Corriere della Sera quoted the text message as saying: “Some walls were knocked down.” And: “I’m outside with a maintenance worker but you can’t see anything of the hotel, there’s only a wall of snow in front of me.” When rescuers on skis arrived in the early morning hours of Thursday, they found just two people alive, according to news reports. Civil protection authorities said that 30 people were missing. The ANSA news agency quoted a rescuer as saying that there were fatalities, but details weren’t immediately available. Just one body was reported removed from the hotel by late morning Thursday. (AP) See more news-related photo galleries and follow us on Yahoo News Photo Tumblr .

      Yahoo News Photo Staff
    • Foreclosed mall once valued at $190M is auctioned for $100

      TARENTUM, Pa. (AP) — A Pennsylvania mall that was foreclosed on after its owners failed to repay $143 million has been auctioned off for $100.

      Associated Press
    • Giant Florida Gator Is Not For Tourists, Nature Preserve Staff Warn

      Officials for the county's natural resources division said, although, they appreciate the attention the nature reserve has been getting, they are also worried about the safety of visitors and wildlife.

      International Business Times
    • Durant dazzles against former Oklahoma City team once more

      OAKLAND, Calif. (AP) — Russell Westbrook promised to pay back Zaza Pachulia for a hard foul.

      Associated Press
    • Ex-president George H.W. Bush moved to intensive care; wife hospitalized

      Bush, who at 92 is the nation's oldest living ex-president, has been at Houston Methodist Hospital since Saturday after experiencing shortness of breath, family spokesman Jim McGrath said on Wednesday. Since then, Bush experienced an "acute respiratory problem stemming from pneumonia" and was sedated for the unspecified procedure, his office said.

      Reuters
    • Everything We Think We Know About the Upcoming Ford Bronco and Ranger

      Ford promises a new small pickup truck and a return of the legendary Bronco name. Here's what to expect.

      Road & Track 16 min ago
    • The internet roasts a photo of Donald Trump writing his inauguration speech

      When times get tough, at least you can still meme. President-elect Donald Trump is slated to deliver his inauguration address on Friday, so he teased his Twitter followers with a little behind-the-scenes photo of himself writing a speech at his Mar-a-Lago estate in Florida. SEE ALSO: Don's Johns: Port-a-potties get censored for Trump’s inauguration Writing my inaugural address at the Winter White House, Mar-a-Lago, three weeks ago. Looking forward to Friday. #Inauguration pic.twitter.com/S701FdTCQu — Donald J. Trump (@realDonaldTrump) January 18, 2017 The staged photo and Trump's cold, dead gaze sent the internet straight into "meme mode alpha," where it was pointed out that Trump was actually holding Sharpie marker, which may or may not actually be closed. @realDonaldTrump that is a blank piece of paper and you're holding a closed sharpie pic.twitter.com/ekCcH8eTXe — Jules Suzdaltsev (@jules_su) January 18, 2017 @cajunmonkey439 @realDonaldTrump It is *obviously* a sharpie. pic.twitter.com/gdD2AUhBKX — Jules Suzdaltsev (@jules_su) January 18, 2017 .@realDonaldTrump pic.twitter.com/8CSroNshBR — XpeK (@peKofX) January 18, 2017 Surprised that you didn't just use this photo as your epic, bigly speech pic.twitter.com/SezwzToFg4 — Roland Scahill (@rolandscahill) January 18, 2017 good job @realDonaldTrump pic.twitter.com/Ioj869Tfy3 — uhhh (@_uhhhhhhh) January 18, 2017 pic.twitter.com/pAKcXAEAkD — Sam Grittner (@SamGrittner) January 18, 2017 @realDonaldTrump #NotMyPresident #TheResistance #conflict #Putin #Inauguration In house security cam Mar a Lago pic.twitter.com/diwnpjAS3F — Beo Bachter (@kaysintBB) January 18, 2017 Early draft of Donald Trump’s inauguration speech. #TrumpSpeech #MyFirstWordsAsPresident #MAGA pic.twitter.com/qgo1glv5cG — Tom ❄️ (@TommieWho) January 18, 2017 Exclusive sneak peek at Trump's inauguration speech! pic.twitter.com/6W6ex0Ks3z — Kara Calavera (@KaraCalavera) January 18, 2017 Trump's Inaugural address leaked... pic.twitter.com/J8soJQ4Ira — Jordan Uhl (@JordanUhl) January 18, 2017 Exclusive: #Trump's Inauguration speech leaked! #TrumpInaugural #trumpgrammar pic.twitter.com/XzrXXpnjxD — Gerry Stergiopoulos (@GerryGreek) January 18, 2017 According to CNN, Trump did write his inauguration speech himself. BONUS: NBD, just a massive alligator out for a stroll

      Mashable
    • A Family's Fight: Mom and Her 1-Year-Old Daughter Battling Cancer Together

      She wasn't expecting her own diagnosis, much less her daughter's.

      Inside Edition
    • When presidential inaugurations go very, very wrong

      As Constitution Daily counts down to Inauguration Day, we look back at three presidential ceremonies from the 1800s that ended very badly.

      National Constitution Center
    • Virginia man convicted of 2006 slaying of family is executed

      JARRATT, Va. (AP) — A man convicted of killing a family of four, slashing their throats and setting their home ablaze after they left their front door open while preparing for a New Year's Day party in 2006, was executed Wednesday.

      Associated Press
    • Undocumented worker sues San Francisco for violating sanctuary law

      The lawsuit was filed on Tuesday on behalf of Pedro Figueroa Zarceno, 32, in federal court in San Francisco against the city and its police chief for violating his right to due process and breaking an ordinance barring municipal employees from cooperating with federal immigration authorities seeking to deport a person. Figueroa walked into a police station in November 2015 to report his car stolen, according to the lawsuit. The civil action comes as San Francisco and dozens of other U.S. cities face pressure from President-elect Donald Trump, who takes office on Friday, to abandon their policies of limiting cooperation between law enforcement officers and U.S. immigration authorities.

      Reuters
    • North Korea's Kim Jong Un Is So Fat He Might Have Hurt His Ankle Again

      Kim's leg injuries have been linked to obesity in the past and recent pictures show the Korean leader appears to have put on extra weight. 

      International Business Times
    • Roethlisberger hoping to play up to Brady's "gold standard"

      Ben Roethlisberger intended for the moment to be private. The camera following him to midfield and the microphone tucked inside Tom Brady's shoulder pads ended up making that impossible. Their brief exchange ...

      Associated Press
    • US stealth bombers kill more than 80 IS fighters in Libya

      More than 80 Islamic State jihadists were killed in a US aerial blitz on training camps in Libya, including fighters involved in plotting attacks in Europe, Defense Secretary Ashton Carter said Thursday. The Pentagon made the highly unusual decision to conduct the air strikes with a pair of B-2 stealth bombers that flew to North Africa on a 34-hour mission from their base in Missouri in America's Midwest. The last time the distinctive, bat-shaped planes were used in Libya was in 2011 during the mission that led to the ouster of longtime leader Moamer Kadhafi.

      AFP 59 min ago
    • Blake Lively Wins First People's Choice Award & Calls Out A Fan

      Not only did she take our breath away on the red carpet, but Blake Lively also melted our ours after winning her first People’s Choice Award

      Clevver News
    • Trump sweeps into Washington with a wave and a salute

      WASHINGTON (AP) — Ready for his big moment, Donald Trump swept into Washington on a military jet Thursday and quickly set to building better ties to the Republican Congress as he kicked off three days of inaugural festivities. Washington braced for an onslaught of crowds and demonstrators — with all the attendant hoopla and hand-wringing.

      Associated Press 33 min ago
    • Fatal Autopilot crash wasn’t Tesla’s fault, investigators decide

      The National Highway Traffic Safety Administration has closed its six-month-old investigation into the fatal crash of a Tesla Model S , which was being driven by the Autopilot system when it collided with a truck last May. The NHTSA will not seek a recall of Tesla's vehicles, and the report said that the agency's examination "did not identify any defects in the design or performance of the Automatic Emergency Braking or Autopilot systems." The crash occurred on a highway in Florida on May 7th last year. The Tesla was being driven a few miles per hour over the speed limit in the left lane of a two-way highway, when a truck with a trailer turned across both lanes towards an exit. The Tesla's radar and cameras failed to pick up the trailer, and the Tesla drove directly into the side of it, killing the driver. Since the accident, Tesla has updated its semi-autonomous Autopilot feature to force drivers to be more hands-on, and treat it like a driving aid rather than an actual Autopilot. Despite the name, Tesla says that Autopilot is still a beta feature that requires drivers to monitor the road just like normal.New Tesla cars also have an updated version of the Autopilot with more sensors, which should prevent a similar accident from happening again. Despite the one fatal crash, Autopilot is statistically safer than human drivers. According to Tesla, Autopiloted vehicles have driven over 200 million miles by this point, with just one fatality. The average for human-driven vehicles is one fatality every 94 million miles, although the numbers are probably skewed a little, as a Tesla is safer than the average car in a crash, and the majority of Autopiloted miles will be driven on divided highways, which are safer than regular roads.

      BGR News